Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to <italic style="font-style: italic">Alternaria alternata</italic> after renal transplantation

ZHANG Ruixia; WANG Yanping; GAO Shan

doi:10.6039/j.issn.1001-0408.2025.04.18

您当前的位置：

首页 >

文章列表页 >

Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to Alternaria alternata after renal transplantation

更新时间：2025-09-26

- Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to Alternaria alternata after renal transplantation
- ZHONGGUO YAOFANG Vol. 36, Issue 4, Pages: 491-495(2025)
- 作者机构：
  
  1.天津市第一中心医院药学部，天津　300192
  2.天津市安定医院药学部，天津　300222
  3.唐山市妇幼保健院药剂科，河北唐山　063000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2025.04.18
  CLC： R969.3
- Received：02 August 2024，
  
  Revised：2025-01-19，
  
  Accepted：20 January 2025，
  
  Published：28 February 2025
- 稿件说明：
移动端阅览
张瑞霞,王岩萍,高珊.1例肾移植术后互隔链格孢菌致肺部感染患者抗感染治疗的药学监护[J].中国药房,2025,36(04):491-495.

ZHANG Ruixia,WANG Yanping,GAO Shan.Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to Alternaria alternata after renal transplantation[J].ZHONGGUO YAOFANG,2025,36(04):491-495.
张瑞霞,王岩萍,高珊.1例肾移植术后互隔链格孢菌致肺部感染患者抗感染治疗的药学监护[J].中国药房,2025,36(04):491-495. DOI： 10.6039/j.issn.1001-0408.2025.04.18.

ZHANG Ruixia,WANG Yanping,GAO Shan.Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to Alternaria alternata after renal transplantation[J].ZHONGGUO YAOFANG,2025,36(04):491-495. DOI： 10.6039/j.issn.1001-0408.2025.04.18.

摘要

目的

为肾移植术后互隔链格孢菌致肺部感染患者治疗方案的选择及药学监护提供参考。

方法

临床药师参与1例肾移植术后互隔链格孢菌致肺部感染患者的抗感染治疗过程，根据患者的临床表现及实验室检查结果并结合文献，临床药师认为患者可能为互隔链格孢菌导致的呼吸道过敏后继发肺部感染，不能排除军团菌和腺病毒感染。临床药师建议口服伏立康唑片抗真菌，莫西沙星片抗军团菌，减少他克莫司剂量，停用更昔洛韦；同时还密切监护患者伏立康唑用药期间的血药谷浓度及可能出现的不良反应。

结果

医生采纳临床药师建议，患者病情平稳后准予出院。

结论

互隔链格孢菌是免疫抑制患者尤其是同时伴有呼吸道过敏反应时的潜在致病菌，伏立康唑可作为其抗感染治疗的首选方案。临床药师通过调整伏立康唑剂量，延长疗程，监测患者肝功能及视觉功能，关注伏立康唑与免疫抑制剂的相互作用等药学服务手段，保障了患者的用药安全。

Abstract

OBJECTIVE

To provide a reference for the selection of anti-infection schemes and pharmaceutical monitoring of pulmonary infection due to

Alternaria alternata

after renal transplantation.

METHODS

The clinical pharmacist was involved in the anti-infective treatment of a patient with pulmonary infection caused by

A. alternata

after renal transplantation. After considering the pati

ent’s clinical symptoms， laboratory test results， and pertinent literature， clinical pharmacists determined that the patient may have developed pulmonary infection as a result of respiratory allergy due to

A. alternata

. The potential for infections from both

Legionella

and

adenovirus

remained a possibility. Oral administration of Voriconazole tablets was recommended for fungal therapy， while Moxifloxacin tablets were suggested for treating

Legionella

. Additionally， it was advised to lower the dosage of tacrolimus and stop using ganciclovir. The pharmacists meticulously tracked the patient’s voriconazole trough levels and any adverse effects that might arise during the therapy.

RESULTS

The physician endorsed the clinical pharmacist’s recommendations， and the patient’s status was steady， permitting discharge.

CONCLUSIONS

A. alternata

is a potential pathogen for immunosuppressed patients， particularly when they also experience respiratory allergic reactions. Voriconazole can serve as the first-line treatment for anti-infection therapy. Clinical pharmacists ensure the patient medication safety by adjusting the dosage of voriconazole， extending the treatment course， monitoring liver and visual functions， and being vigilant about the interaction between voriconazole and immunosuppressants.

关键词

Keywords

references

ABEL-FERNÁNDEZ E ， MARTÍNEZ M J ， GALÁN T ， et al . Going over fungal allergy： Alternaria alternata and its allergens [J ] . J Fungi（Basel）， 2023 ， 9 （ 5 ）： 582 .

KIM G ， YOO S J ， YOO J R ， et al . The first case report of thorn-induced Alternaria alternata infection of the hand in an immunocompetent host [J ] . BMC Infect Dis ， 2022 ， 22 （ 1 ）： 304 .

CHEN J J ， YAO H ， YUAN X L ， et al . Palatal perforation caused by Alternaria alternata infection in an immunocompetent adolescent [J ] . Int J Infect Dis ， 2023 ， 134 ： 207 - 210 .

SELF W H ， WILLIAMS D J ， ZHU Y W ， et al . Respiratory viral detection in children and adults：comparing asymptomatic controls and patients with community-acquired pneumonia [J ] . J Infect Dis ， 2016 ， 213 （ 4 ）： 584 - 591 .

BRUMINHENT J ， WORAWICHAWONG S ， TONGSOOK C ， et al . Epidemiology and outcomes of early-onset and late-onset adenovirus infections in kidney transplant recipients [J ] . Open Forum Infect Dis ， 2019 ， 6 （ 12 ）： ofz489 .

YING B L ， TOLLEFSON A E ， SPENCER J F ， et al . Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters [J ] . Antimicrob Agents Chemother ， 2014 ， 58 （ 12 ）： 7171 - 7181 .

中国医药教育协会感染疾病专业委员会 . 降钙素原指导抗菌药物临床合理应用专家共识 [J ] . 中华医学杂志， 2020 ， 100 （ 36 ）： 2813 - 2821 .

Infectious Diseases Professional Committee of China Medicine Education Association . Expert consensus on the rational clinical use of antibiotics guided by procalcitonin [J ] . Natl Med J China ， 2020 ， 100 （ 36 ）： 2813 - 2821 .

SIVAGNANAM S ， PODCZERVINSKI S ， BUTLER-WU S M ， et al . Legionnaires’ disease in transplant recipients：a 15-year retrospective study in a tertiary referral center [J ] . Transpl Infect Dis ， 2017 ， 19 （ 5 ）： e12745 .

HAEUPTLE J ， ZABORSKY R ， FIUMEFREDDO R ， et al . Prognostic value of procalcitonin in Legionella pneumonia [J ] . Eur J Clin Microbiol Infect Dis ， 2009 ， 28 （ 1 ）： 55 - 60 .

DEMERS M . Alternaria alternata as endophyte and pathogen [J ] . Microbiology（Reading）， 2022 ， 168 （ 3 ）： 001153 .

MAISONS V ， DESOUBEAUX G ， COUSTILLÈRES F ， et al . Intricate isavuconazole therapy of a subcutaneous nodule caused by Alternaria infectoria in a heart transplant recipient [J ] . J Mycol Med ， 2022 ， 32 （ 2 ）： 101235 .

IOSSIFOVA Y ， REPONEN T ， SUCHAREW H ， et al . Use of（1-3）-beta-d-glucan concentrations in dust as a surrogate method for estimating specific fungal exposures [J ] . Indoor Air ， 2008 ， 18 （ 3 ）： 225 - 232 .

BEN-AMI R ， ROCCO LASALA P ， LEWIS R E ， et al . Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis [J ] . Diagn Microbiol Infect Dis ， 2010 ， 66 （ 2 ）： 200 - 203 .

OGAWA H ， FUJIMURA M ， AMAIKE S ， et al . Eosinophilic pneumonia caused by Alternaria alternata [J ] . Allergy ， 1997 ， 52 （ 10 ）： 1005 - 1008 .

CHOWDHARY A ， AGARWAL K ， RANDHAWA H S ， et al . A rare case of allergic bronchopulmonary mycosis caused by Alternaria alternata [J ] . Med Mycol ， 2012 ， 50 （ 8 ）： 890 - 896 .

SHASHIKALA R P ， SAIKUMAR A ， RAMESH K ， et al . Alternaria alternata in a case of mass in the lung [J ] . Indian J Med Microbiol ， 2013 ， 31 （ 3 ）： 308 - 310 .

SEČNÍKOVÁ Z ， JŮZLOVÁ K ， VOJÁČKOVÁ N ， et al . The rare case of Alternaria alternata cutaneous and pulmonary infection in a heart transplant recipient treated by azole antifungals [J ] . Dermatol Ther ， 2014 ， 27 （ 3 ）： 140 - 143 .

GONZÁLEZ G M . In vitro activities of isavuconazol e against opportunistic filamentous and dimorphic fungi [J ] . Med Mycol ， 2009 ， 47 （ 1 ）： 71 - 76 .

ALASTRUEY-IZQUIERDO A ， CUESTA I ， ROS L ， et al . Antifungal susceptibility profile of clinical Alternaria spp. identified by molecular methods [J ] . J Antimicrob Chemother ， 2011 ， 66 （ 11 ）： 2585 - 2587 .

PASTOR F J ， GUARRO J . Alternaria infections：laboratory diagnosis and relevant clinical features [J ] . Clin Microbiol Infect ， 2008 ， 14 （ 8 ）： 734 - 746 .

GERDSEN R ， UERLICH M ， DE HOOG G S ， et al . Sporotrichoid phaeohyphomycosis due to Alternaria infectoria [J ] . Br J Dermatol ， 2001 ， 145 （ 3 ）： 484 - 486 .

石炳毅，巨春蓉 . 器官移植受者侵袭性真菌病临床诊疗技术规范： 2019版 [J ] . 器官移植， 2019 ， 10 （ 3 ）： 227 - 236 .

SHI B Y ， JU C R . Technical specification for clinical diagnosis and treatment for invasive fungal disease in organ transplant recipients：2019 edition [J ] . Organ Transplant ， 2019 ， 10 （ 3 ）： 227 - 236 .

陈恳，张相林，克晓燕，等 . 《伏立康唑个体化用药指南》解读 [J ] . 临床药物治疗杂志， 2019 ， 17 （ 3 ）： 47 - 52，78 .

CHEN K ， ZHANG X L ， KE X Y ， et al . Executive summary of The Practice Guideline for Individualized Medication of Voriconazole [J ] . Clin Med J ， 2019 ， 17 （ 3 ）： 47 - 52，78 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmaceutical care for the HIV-negative patient with disseminated Talaromyces marneffei osteomyelitis complicated by pulmonary tuberculosis

Expert consensus on rational medication management of targeted PI3K/Akt/mTOR inhibitors in breast cancer

Individualized treatment and pharmaceutical care for breast cancer complicated with chronic kidney disease

Anticoagulation therapy analysis and pharmaceutical care for a breast cancer patient with pulmonary thromboembolism accompanied by multiple comorbidities

Pharmaceutical care for a patient with empagliflozin-induced euglycemic diabetic ketoacidosis

Related Author

ZHANG Qinghua

HE Liting

Writing Group of Expert Consensus on Rational Medication Management of Targeted PI3K/Akt/mTOR Inhibitors in Breast Cancer

任天舒

赵庆春

ZHANG Ming

YU Lu

WU Xudong

Related Institution

Dept. of Pharmacy， Jiangmen Central Hospital

Dept. of Internal Medicine， Zhonggongmiao Community Hospital of Ningbo Yinzhou District No.2 Hospital Medical Community

Dept. of Clinical Pharmacy， Ningbo Yinzhou District No.2 Hospital

Dept. of Pulmonary & Critical Care Medicine， Ruijin Hospital， Shanghai Jiao Tong University School of Medicine

Dept. of Pharmacy， Ruijin Hospital， Shanghai Jiao Tong University School of Medicine

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to Alternaria alternata after renal transplantation

DOI：10.6039/j.issn.1001-0408.2025.04.18

摘要

Abstract

关键词

Keywords

references